About Stacy Lawrence

Stacy Lawrence

Stacy Lawrence has been writing and editing about the business of emerging technologies for almost 20 years. Most recently, she was editor-in-chief of FierceBiotech, where she covered biotech and medtech. She’s also held spots as the biopharma business bureau editor with Elsevier and the finance columnist with biotechnology industry publication BioCentury. Stacy has contributed to publications including Nature Biotechnology, San Francisco Business Times, New Scientist, MIT Technology Review, Business 2.0, and Wired.

Latest Contributions